BaseSpace
Correlation Engine 2.0
Import Your Data
Literature

FAQ

More FAQs

Back to top
Clear Search sequence regions
(e.g. Angiogenesis, Obesity, Heart, DNA fingerprint, Valproic acid, rs2476601, FGF21)
Bookmark Forward

Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failure.

Brian J Ball, Christopher A Famulare, Eytan M Stein, Martin S Tallman, Andriy Derkach, Mikhail Roshal, Saar I Gill, Benjamin M Manning, Jamie Koprivnikar, James McCloskey, Rebecca Testi, Thomas Prebet, Najla H Al Ali, Eric Padron, David A Sallman, Rami S Komrokji, Aaron D Goldberg

Blood advances 2020 Jul 14


filter terms:
  • bicyclo compounds (2)
  • humans (1)
  • patients (1)
    • Sizes of these terms reflect their relevance to your search.

    No abstract available.

    Citation

    Brian J Ball, Christopher A Famulare, Eytan M Stein, Martin S Tallman, Andriy Derkach, Mikhail Roshal, Saar I Gill, Benjamin M Manning, Jamie Koprivnikar, James McCloskey, Rebecca Testi, Thomas Prebet, Najla H Al Ali, Eric Padron, David A Sallman, Rami S Komrokji, Aaron D Goldberg. Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failure. Blood advances. 2020 Jul 14;4(13):2866-2870

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 32589727

    View Full Text
    • Copyright © 2024 Illumina Inc. All rights reserved.